Potential therapeutic targets identified for multiple sclerosis

January 25, 2016
Demyelination by MS. The CD68 colored tissue shows several macrophages in the area of the lesion. Original scale 1:100. Credit: Marvin 101/Wikipedia

Treatment of multiple sclerosis (MS) and other inflammatory diseases may benefit by new findings from a study that identified potential therapeutic targets for a devastating disease striking some 2.3 million people worldwide.

Inflammation is an important part of body's response against infections and tissue damage, but unresolved inflammation contributes to the pathogenesis of a variety of diseases and promotes cancer development.

The study, led by researchers at The University of Texas MD Anderson Cancer Center, described a protein regulator known as Trabid as an important piece of the puzzle that leads to autoimmune inflammation of the central nervous systems in MS patients.

Study results were published in the Jan. 25 online issue of Nature Immunology.

"Our findings highlight an epigenetic mechanism for the regulation of the cytokine genes, IL-12 and IL-23, and established Trabid as an immunological regulator of inflammatory T-cell responses," said Shao-Cong Sun, Ph.D., professor of Immunology. "Trabid appeared to regulate histone modifications by controlling the fate of a histone demethylase called Jmjd2d."

Cytokines are small proteins important for cell signaling, and IL-12 and IL-23 are mediators of inflammation and associated with . Sun believes that Trabid and Jmjd2d may be for the treatment of inflammatory diseases such as MS.

"Since chronic inflammation is a major risk of cancer, future studies will examine whether Trabid and Jmjd2d also have a role in cancer development," said Sun.

Pro-inflammatory cytokines like IL-12 and IL-23 connect innate responses and immune responses and are also involved in autoimmune and inflammatory diseases, said the researchers. The innate immune system, also known as the nonspecific immune system, is an important subsystem of the overall immune system that comprises the cells and mechanisms that defend the host from infection by other organisms.

"Cells of the innate immune system including dendritic cells and macrophages, have an important role in regulating the nature and magnitude of adaptive immune responses," said Sun. "They recognize microbial components including various receptors that trigger intracellular signaling events that impact the function of those cells. Deregulated production of pro-inflammatory cytokines by cells of the innate also contributes to autoimmune and inflammatory diseases."

Sun's team found that deletion of a protein-coding gene known as Zranb1, which encodes Trabid, in inhibited expression of IL-12 and IL-23, impairing differentiation of inflammatory T-cells. The process protected study mice from autoimmune .

Explore further: Will blocking IL-17A help treat kidney disease?

More information: Epigenetic regulation of Il12 and Il23 gene expression and autoimmune inflammation by the deubiquitinase Trabid, DOI: 10.1038/ni.3347

Related Stories

Will blocking IL-17A help treat kidney disease?

January 22, 2016
Many different diseases and insults can injure kidneys, resulting in kidney failure. Some autoimmune diseases damage glomeruli (the 'filtering units' of the kidney), while problems with the tubules (for example, impaired ...

Protein identified that serves as a 'brake' on inflammation

April 21, 2015
Researchers have identified a protein that offers a new focus for developing targeted therapies to tame the severe inflammation associated with multiple sclerosis (MS), colitis and other autoimmune disorders. St. Jude Children's ...

Studying 'inflamm-aging': Monocytes, cytokines, and susceptibility to pneumonia

January 14, 2016
The chronic state of low-level inflammation seen in many elderly individuals (sometimes called "inflamm-aging"), is associated with diseases such as cardiovascular disease and dementia, as well as susceptibility to infections, ...

Slowing down the immune system when in overdrive

February 10, 2014
Many people suffer from chronic inflammation because their immune systems overreact to 'self' tissue. Sydney scientists believe that a small molecule known as Interleukin 21 is a promising therapeutic target in such cases.

Interleukin-27: Can a cytokine with both pro and anti-inflammatory activity make a good drug target?

October 20, 2014
Interleukin-27 (IL-27), a member of the interleukin family of cytokines that help regulate the immune system, has a mainly anti-inflammatory role in the body, and its dysfunction has been implicated in autoimmune diseases ...

Signaling pathway helps protect healthy tissue from overly active immune responses

February 5, 2015
Researchers have uncovered a pathway that's key for protecting healthy tissue from overly active immune responses. The findings, which are described in an upcoming issue of the Journal of the American Society of Nephrology ...

Recommended for you

Drug could cut transplant rejection

November 21, 2017
A diabetes drug currently undergoing development could be repurposed to help end transplant rejection, without the side-effects of current immunosuppressive drugs, according to new research by Queen Mary University of London ...

Atopic eczema—one size does not fit all

November 21, 2017
Researchers from the UK and Netherlands have identified five distinct subgroups of eczema, a finding that helps explain how the condition can affect people at different stages of their lives.

Study explores whole-body immunity

November 21, 2017
Over the next few months, millions of people will receive vaccinations in the hope of staving off the flu—and the fever, pain, and congestion that come with it.

Breast milk found to protect against food allergy

November 20, 2017
Eating allergenic foods during pregnancy can protect your child from food allergies, especially if you breastfeed, suggests new research from Boston Children's Hospital. The study, published online today in the Journal of ...

Zika-related nerve damage caused by immune response to the virus

November 20, 2017
The immune system's response to the Zika virus, rather than the virus itself, may be responsible for nerve-related complications of infection, according to a Yale study. This insight could lead to new ways of treating patients ...

How a poorly explored immune cell may impact cancer immunity and immunotherapy

November 17, 2017
The immune cells that are trained to fight off the body's invaders can become defective. It's what allows cancer to develop. So most research has targeted these co-called effector T-cells.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.